Quantum Biopharma (QNTM) Free Cash Flow (2019 - 2026)
Quantum Biopharma (QNTM) reported Free Cash Flow of $1.3 million for Q1 2026, up 188.54% on a YoY basis from $448281.6 in Q1 2025, and up 523.27% sequentially from -$305598.0 in Q4 2025.
Quantum Biopharma (QNTM) Free Cash Flow (2019 - 2026) Analysis & Trends
Quantum Biopharma (QNTM) has 8 years of Free Cash Flow data on file, last reported at $1.3 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow rose 188.54% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at -$350748.0 (up 94.51% YoY), and the FY2025 full-year result was -$8.2 million, down 19.79% from the prior year.
- Free Cash Flow improved to $1.3 million in Q1 2026, from -$305598.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $9.4 million in Q2 2022 to a low of -$50.6 million in Q4 2022.
- A 5-year average of -$2.5 million and a median of -$502045.0 in 2025 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow tumbled 31491.93% in 2025 and soared 188.54% in 2026, its largest moves.
- Tracing QNTM's Free Cash Flow over 5 years: stood at -$50.6 million in 2022, then surged by 98.53% to -$744500.0 in 2023, then sank by 480.41% to -$4.3 million in 2024, then surged by 92.93% to -$305598.0 in 2025, then surged by 523.27% to $1.3 million in 2026.
- Business Quant data shows QNTM's Free Cash Flow at $1.3 million in Q1 2026, -$305598.0 in Q4 2025, and -$836595.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 158.09 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -354.95 Mn |
| 10 | Quantum Biopharma | 13.00 Bn | 13.00 Bn | - | 1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.29 Mn |
| Mar 31, 2026 | 1.29 Mn |
| Dec 31, 2025 | -305,598.00 |
| Dec 31, 2025 | -305,598.00 |
| Sep 30, 2025 | -836,595.00 |
| Sep 30, 2025 | -836,595.00 |
| Jun 30, 2025 | -502,045.00 |
| Jun 30, 2025 | -502,045.00 |
| Mar 31, 2025 | -1.46 Mn |
| Mar 31, 2025 | -1.46 Mn |
| Dec 31, 2024 | -4.32 Mn |
| Dec 31, 2024 | -4.32 Mn |
| Sep 30, 2024 | 2,665.00 |
| Sep 30, 2024 | 2,665.00 |
| Jun 30, 2024 | -606,704.00 |
| Jun 30, 2024 | -606,704.00 |
| Mar 31, 2024 | -1.95 Mn |
| Mar 31, 2024 | -1.95 Mn |
| Dec 31, 2023 | -744,500.00 |
| Dec 31, 2023 | -744,500.00 |